The Mississippi State Department of Health released a statement Friday that the department is committed to meeting the statutory requirements of the new Mississippi Medical Cannabis Act.

“The goal is to provide a safe and accessible program that meets the needs of patients and the public health and safety of all Mississippi residents,” the statement read. “The MSDH is currently working to establish the licensing and patient registry structures and plans to begin accepting online license applications for patients, medical practitioners, cannabis cultivation facilities, and others by June 2022.”

The long list of medical conditions or treatments that qualify for participation in the Mississippi Medical Cannabis Program include: cancer, Parkinson’s disease, Huntington’s disease, glaucoma, muscular dystrophy, HIV, AIDS, ALS, diabetic/peripheral neuropathy and post-traumatic stress disorder.

To find out more about the MMC Program, visit MSDH online.

Read the full 445-page text of the Act here.